Clofarabine plus Low-Dose Cytarabine Followed by Clofarabine plus Low-Dose Cytarabine Alternating with Decitabine in AML Frontline Therapy of Older Patients

Eitemau Tebyg

• Final Results of a Phase II Trial of Clofarabine and Low-Dose Cytarabine Alternating with Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia
  gan: Kadia, Tapan M., et al.
  Cyhoeddwyd: (2015)
• Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients
  gan: Takahashi, Koichi, et al.
  Cyhoeddwyd: (2015)
• A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
  gan: Faderl, Stefan, et al.
  Cyhoeddwyd: (2008)
• Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients ≤60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)
  gan: Nazha, Aziz, et al.
  Cyhoeddwyd: (2013)
• Phase II Single-Arm Trial of Cladribine and Low-Dose Cytarabine Alternating with Decitabine as Frontline Therapy for Older Patients with Acute Myeloid Leukemia
  gan: Kadia, Tapan M., et al.
  Cyhoeddwyd: (2018)